Background: This study is a quantitative and qualitative assessment of the global research trends on amyotrophic lateral sclerosis (ALS) (popularly known as Ice Bucket Challenge), through related literatures retrieved from SCOPUS multidisciplinary database for the period 1974-2013. Purpose: This study is aimed at analyzing the literature on ALS in terms of document type, language, annual growth, productive country, journal, authors, subject, and most cited articles. Methods: The bibliographic data for this study was retrieved from the SCOPUS database using keywords ‘amyotrophic lateral sclerosis', ‘motor neurone disease', ‘Charcot disease', ‘Lou Gehrig's disease', ‘Ice Bucket Challenge' available in title, abstract, and keyword fields of Scopus database from 1974 to 2013. Results: The literature analysis included 21,750 articles during the period from 1974 to 2013 in different areas of ALS. USA was the most productive country in terms of literature produced, while Neurology was the most productive journal. Conclusion: An intensive awareness created by ‘Ice Bucket Challenge' has attracted masses, and an intensive growth of literature is pertinent on ALS. The results of this study are expressed in terms of growth of literature, output of individual countries, and authors, and will be helpful in collaborative research in future.

1.
Ferrier D: National hospital for the paralysed and epileptic. Cases of amyotrophic lateral sclerosis. Lancet 1881;117:822-823.
2.
INDEPENDENT: George Bush Delivers Possibly the Best ALS Ice Bucket Challenge Yet (retrieved August 20, 2014).
3.
Metro: 10 of the Best Celebrity Ice Bucket Challenges (retrieved August 20, 2014).
4.
Guardian: The 10 Best Celebrity Takes on the Ice Bucket Challenge (retrieved August 20, 2014).
5.
Johnson JO, Mandrioli J, Benatar M, Abramzon Y, Van Deerlin VM, Trojanowski JQ, et al: Exome sequencing reveals VCP mutations as a cause of familial ALS. Neuron 2010;68:857-864.
6.
NIH: Amyotrophic Lateral Sclerosis (ALS) Fact Sheet. http://www.ninds.nih.gov/disorders/amyotrophiclateralsclerosis/detail_als.htm.
7.
Mela GS, Cimmino MA: An overview of rheumatological research in the European Union. Ann Rheum Dis 1998;57:643-647.
8.
Li T, Ho YS, Li CY: Bibliometric analysis on global Parkinson's disease research trends during 1991-2006. Neurosci Lett 2008;441:248-252.
9.
Ansari MA, Khan A: Parkinson's disease: a bibliometric profile. Trend Info Manag 2008;3:58-68.
10.
Ponce FA, Lozano AM: The most cited works in Parkinson's disease. Mov Disord 2011;26:380-390.
11.
Ansari MA, Gul S, Yaseen M: Alzheimer's disease: a bibliometric study. Trend Inform Manag 2006;2:130-140.
12.
Sorensen AA: Alzheimer's disease research: scientific productivity and impact of the top 100 investigators in the field. J Alzheimers Dis 2009;16:451-465.
13.
Sorensen AA, Seary A, Riopelle K: Alzheimer's disease research: a COIN study using co-authorship network analytics. Proced Soc Behav Sci 2010;2:6582-6586.
14.
Chen H, Wan Y, Jiang S, Cheng Y: Alzheimer's disease research in the future: bibliometric analysis of cholinesterase inhibitors from 1993 to 2012. Scientometrics 2014;98:1865-1877.
15.
Ram S: India's contribution on ‘Guillain-Barre syndrome': mapping of 40 years research. Neurol India 2013;61:375-382.
16.
Gupta BM, Bala A: Alzheimer's disease research in India: a scientometric analysis of publications output during 2002-2011. Res Neurol 2013;11:204542.
17.
Gupta BM, Bala A: Parkinson's disease in India: an analysis of publications output during 2002-2011. Int J Nutr Pharmacol Neurol Dis 2013;3:254-262.
18.
Hirsch JE: An index to quantify an individual's scientific research output. Proc Natl Acad Sci U S A 2005;102:16569-16572.
19.
Marx W, Cardona M: The impact of solid state communications in view of the ISI citation data, Solid State Commun 2003;127:323-336.
20.
Beckman JS, Koppenol WH: Nitric oxide, superoxide, and peroxynitrite: the good, the bad, and ugly. Am J Physiol 1996;271(5 pt 1):C1424-C1437.
21.
De Winter JCF, Zadpoor AA, Dodou D: The expansion of Google Scholar versus Web of Science: a longitudinal study. Scientometrics 2014;98:1547-1565.
22.
Aversa ES: Citation patterns of highly cited papers and their relationship to literature aging: a study of the working literature. Scientometrics 1985;7:383-389.
23.
Stent GS: Prematurity and uniqueness in scientific discovery. Sci Am 1972;227:84-93.
24.
Garfield E: Premature discovery or delayed recognition - why. Curr Contents 1980;21:5-10.
25.
Van Raan AFJ: Sleeping beauties in science. Scientometrics 2004;59:467-472.
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.